Metabolic benefits of growth hormone therapy in idiopathic short stature

Hormone Research in Paediatrics

Volumn 76, Issue SUPPL. 3, 2011, Pages 56-58

  Dahlgren, Jovanna ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Growth hormone treatment; Height gain; Idiopathic short stature; Insulin sensitivity; Metabolic outcome

Indexed keywords

HUMAN GROWTH HORMONE; SOMATOMEDIN C;

CHILDHOOD DISEASE; CONFERENCE PAPER; DIABETES MELLITUS; DOSE RESPONSE; DRUG APPROVAL; DRUG EFFECT; FOOD AND DRUG ADMINISTRATION; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HUMAN; IDIOPATHIC DISEASE; INSULIN SENSITIVITY; METABOLIC DISORDER; METABOLISM; PRIORITY JOURNAL; RISK ASSESSMENT; SHORT STATURE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ADIPOSE TISSUE; ADOLESCENT; BODY HEIGHT; CHILD; DWARFISM; DWARFISM, PITUITARY; GLUCOSE; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; LIPID METABOLISM; MALE; RECOMBINANT PROTEINS;

EID: 80052744674     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000330165     Document Type: Conference Paper

References (18)

1. Jeffcoate W: Growth hormone therapy and its relationship to insulin resistance, glucose intolerance and diabetes mellitus: A review of recent evidence. Drug Saf 2002; 25: 199-212. (Pubitemid 34492939)
2. Sas T, Mulder P, Aanstoot HJ, Houdijk M, Jansen M, Reeser M, Hokken- Koelega A: Carbohydrate metabolism during long-term growth hormone treatment in children with short stature born small for gestational age. Clin Endocrinol (Oxf) 2001; 54: 243-251. (Pubitemid 32193527)
3. Hokken-Koelega AC, van Pareren Y, Sas T, Arends N: Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age. Horm Res 2003; 60(suppl 3):113-114. (Pubitemid 37548213)
4. Bougneres PF, Artavia-Loria E, Ferre P, Chaussain JL, Job JC: Effects of hypopituitarism and growth hormone replacement therapy on the production and utilization of glucose in childhood. J Clin Endocrinol Metab 1985; 61: 1152-1157. (Pubitemid 16186718)
5. Costin G, Kogut MD, Frasier SD: Effect of low-dose growth hormone on carbohydrate metabolism in children with hypopituitarism. J Pediatr 1972; 80: 796-803.
6. Lippe BM, Kaplan SA, Golden MP, Hendricks SA, Scott ML: Carbohydrate tolerance and insulin receptor binding in children with hypopituitarism: Responses after acute and chronic growth hormone administration. J Clin Endocrinol Metab 1981; 53: 507-513. (Pubitemid 12005790)
7. Kriström B, Jansson C, Rosberg S, Albertsson-Wikland K: Growth response to growth hormone (GH) treatment relates to serum insulinlike growth factor I (IGF-I) and IGF-binding protein-3 in short children with various GH secretion capacities. Swedish Study Group for Growth Hormone Treatment. J Clin Endocrinol Metab 1997; 82: 2889-2898. (Pubitemid 27385644)
8. Cutfield WS, Lundgren F: Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, Turner syndrome and born small for gestational age. Horm Res 2009; 71(suppl 1):39-45.
9. Kriström B, Carlsson B, Rosberg S, Carlsson LM, Albertsson-Wikland K: Short-term changes in serum leptin levels provide a strong metabolic marker for the growth response to growth hormone treatment in children. Swedish Study Group for Growth Hormone Treatment. J Clin Endocrinol Metab 1998; 83: 2735-2741.
10. Wit JM, Rekers-Mombarg LT; Dutch Growth Hormone Advisory Group: Final height gain by GH therapy in children with idiopathic short stature is dose dependent. J Clin Endocrinol Metab 2002; 87: 604-611. (Pubitemid 34158225)
11. Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL, Chernausek SD, Savage MO, Wit JM; 2007 ISS Consensus Workshop participants: Consensus statement on the diagnosis and treatment of children with idiopathic short stature: A summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab 2007; 93: 4210-4217. (Pubitemid 352806728)
12. Saenger P, Attie KM, DiMartino-Nardi J, Hintz R, Frahm L, Frane JW: Metabolic consequences of 5-year growth hormone (GH) therapy in children treated with GH for idiopathic short stature. Genentech Collaborative Study Group. J Clin Endocrinol Metab 1998; 83: 3115-3120. (Pubitemid 28500944)
13. Quigley CA, Gill AM, Crowe BJ, Robling K, Chipman JJ, Rose SR, Ross JL, Cassorla FG, Wolka AM, Wit JM, Rekers-Mombarg LT, Cutler GB Jr: Safety of growth hormone treatment in pediatric patients with idiopathic short stature. J Clin Endocrinol Metab 2005; 90: 5188-5196. (Pubitemid 41262273)
14. Kamp GA, Zwinderman AH, Van Doorn J, Hackeng W, Frölich M, Schönau E, Wit JM: Biochemical markers of growth hormone (GH) sensitivity in children with idiopathic short stature: Individual capacity of IGF-I generation after high-dose GH treatment determines the growth response to GH. Clin Endocrinol (Oxf) 2002; 57: 315-325. (Pubitemid 35013810)
15. Hannon TS, Danadian K, Suprsongsin C, Arslanian SA: Growth hormone treatment in adolescent males with idiopathic short stature: Changes in body composition, protein, fat, and glucose metabolism. J Clin Endocrinol Metab 2007; 92: 3033-3039. (Pubitemid 47236367)
16. Kriström B, Aronson AS, Dahlgren J, Gustafsson J, Halldin M, Ivarsson SA, Nilsson NO, Svensson J, Tuvemo T, Albertsson-Wikland K: Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature. J Clin Endocrinol Metab 2009; 94: 483-490.
17. Boguszewski M, Jansson C, Rosberg S, Albertsson-Wikland K: Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein- 3 levels during growth hormone treatment in prepubertal short children born small for gestational age. J Clin Endocrinol Metab 1996; 81: 3902-3908. (Pubitemid 26380394)
18. Decker R, Albertsson-Wikland K, Kriström B, Nierop AF, Gustafsson J, Bosaeus I, Fors H, Hochberg Z, Dahlgren J: Metabolic outcome of GH treatment in prepubertal short children with and without classical GHdeficiency. Clin Endocrinol (Oxf) 2010; 73: 346-354.